| |
| |
|
| Insider
Information: |
Kintz Samuel |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
1,264,587 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,264,587 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enliven Therapeutics Ord Shs |
ELVN |
|
2024-04-25 |
0 |
2024-04-25 |
1,264,587 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-04-25 |
4 |
AS |
$16.89 |
$202,700 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-04-25 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-04-11 |
4 |
AS |
$25.04 |
$1,194,700 |
D/D |
(47,709) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-04-11 |
4 |
OE |
$1.12 |
$53,434 |
D/D |
47,709 |
47,709 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-03-25 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-03-25 |
4 |
AS |
$17.17 |
$210,661 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-02-26 |
4 |
AS |
$16.69 |
$202,653 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
PRESIDENT AND CEO |
• • – |
2024-02-26 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2024-01-25 |
4 |
AS |
$14.94 |
$188,229 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2024-01-25 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-26 |
4 |
AS |
$14.64 |
$175,709 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-26 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-22 |
4 |
AS |
$13.05 |
$106,655 |
D/D |
(8,175) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-22 |
4 |
OE |
$1.12 |
$9,156 |
D/D |
8,175 |
8,175 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-21 |
4 |
AS |
$13.00 |
$260 |
D/D |
(20) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-21 |
4 |
OE |
$1.12 |
$22 |
D/D |
20 |
20 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-20 |
4 |
OE |
$1.12 |
$8,712 |
D/D |
7,779 |
7,779 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-12-20 |
4 |
AS |
$13.01 |
$101,238 |
D/D |
(7,779) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-11-03 |
4 |
AS |
$13.08 |
$104,999 |
D/D |
(8,026) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-11-03 |
4 |
OE |
$1.12 |
$8,989 |
D/D |
8,026 |
8,026 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-09-25 |
4 |
AS |
$13.81 |
$165,691 |
D/D |
(12,000) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-09-25 |
4 |
OE |
$1.12 |
$13,440 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
President and CEO |
• • – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,264,587 |
88,531 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
